Cardiometabolic Disease and Pulmonary Hypertension
Status:
Terminated
Trial end date:
2020-12-22
Target enrollment:
Participant gender:
Summary
This study will investigate if metformin can help people with obesity and high pressures
inside their lung blood vessels. Metformin is approved by the U.S. Food and Drug
Administration (FDA) to treat diabetes, but metformin is not approved by the FDA to treat
pulmonary hypertension.
This study will examine whether Metformin will improve the high pressure inside lung blood
vessels in people who are obese. The study will help understand the effect of metformin on
pressures inside lung blood vessels.